Prescribing information can be found here.
Fixkoh Airmaster is a dry powder inhaler indicated for adults and adolescents 12 years of age and older in the regular treatment of asthma and for the symptomatic treatment of patients with COPD.2,3,4
Therapeutically equivalent to Seretide® Accuhaler® 5 for formulation and device characteristics, Fixkoh Airmaster offers:
✓ A COST-EFFECTIVE salmeterol/fluticasone DPI range1
✓ All THREE strengths of ICS in the same device-type2,3,4
✓ Implementation SUPPORT for you and your patients
References
† Pharmacy Management Journal. Available here. Access date: August 2023.
* Thornton & Ross Ltd. 2021. Fixkoh Airmaster™ % cost saving based on approved NHS prices: Fixkoh Airmaster™ 50/100 mcg: £14.47 Fixkoh Airmaster™ 50/250 mcg: £19.29 Fixkoh Airmaster™ 50/500 mcg: £16.12 versus NHS indicative price of same strength salmeterol/fluticasone DPI. Available here. Access date: August 2023.
1. NICE BNF online. Fluticasone with Salmeterol. Medicinal forms. Available here. Access date: August 2023.
2. Fixkoh Airmaster 50mcg/100mcg SmPC. Available here. Access date: August 2023.
3. Fixkoh Airmaster 50mcg/250mcg SmPC. Available here. Access date: August 2023.
4. Fixkoh Airmaster 50mcg/500mcg SmPC. Available here. Access date: August 2023.
5. Swedish Medical Products Agency. Public Assessment Report: Scientific discussion. Sipova Airmaster. 2019. Available here. Access date: August 2023.
6. NHS England. Delivering a ‘Net Zero’ National Health Service. 2021. Available here. Access date: August 2023.
Seretide® and Accuhaler® are registered trademarks of the GlaxoSmithKline group of companies.
UK-FIXK-39(3) | August 2023
